Skip to main content
SpringerLink
Log in

Enoxaparin preferred option for VTE prevention after THR in China

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Sponsorship for the study was funded by Sanofi China.

Reference

  • Yan X, et al. Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China. Advances in Therapy : 20 Dec 2016. Available from: URL: http://doi.org/10.1007/s12325-016-0460-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Enoxaparin preferred option for VTE prevention after THR in China. PharmacoEcon Outcomes News 769, 11 (2017). https://doi.org/10.1007/s40274-017-3647-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3647-y

Search

Navigation